After PTI, mice showed substantial deficits in the grid-walking and adhesive removal tests, whereas SARM1 deletion improved performance at 3 d post ischemic stroke, and this advantage persisted for 14 d (Fig. 2A). Here, SARM1 is linked to ischemic stroke.